Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Clinical trial NCT02921035 · COMPLETED

Trial details

NCT number: NCT02921035
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis (RMS)

Start date: 2016-06-30
Primary completion: 2020-07-27
Enrollment: 594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.